{"id":"https://openalex.org/W7204996877","doi":"https://doi.org/10.1158/1535-7163.c.8688008","title":"Data from Amanitin-Based Fc-Small Molecule\u2013Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy","display_name":"Data from Amanitin-Based Fc-Small Molecule\u2013Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy","publication_year":2026,"publication_date":"2026-09-02","ids":{"openalex":"https://openalex.org/W7204996877","doi":"https://doi.org/10.1158/1535-7163.c.8688008"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.8688008","doi":"https://doi.org/10.1158/1535-7163.c.8688008","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8688008","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.8688008","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008755711","display_name":"Daniela Carraturo","orcid":"https://orcid.org/0009-0000-4034-0884","observed_orcids":["https://orcid.org/0009-0000-4034-0884"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Carraturo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-4034-0884","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147268117","display_name":"Francesca Gallo","orcid":"https://orcid.org/0009-0006-4834-9035","observed_orcids":["https://orcid.org/0009-0006-4834-9035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Gallo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-4834-9035","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148956754","display_name":"Marisa Schmitt","orcid":"https://orcid.org/0009-0009-1374-3421","observed_orcids":["https://orcid.org/0009-0009-1374-3421"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marisa Schmitt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-1374-3421","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051509432","display_name":"Kristin Decker","orcid":"https://orcid.org/0009-0009-4785-2503","observed_orcids":["https://orcid.org/0009-0009-4785-2503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristin Decker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-4785-2503","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039626398","display_name":"Christian Orlik","orcid":"https://orcid.org/0000-0001-5877-0313","observed_orcids":["https://orcid.org/0000-0001-5877-0313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Orlik","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5877-0313","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062654257","display_name":"Andreas M. Pahl","orcid":"https://orcid.org/0000-0002-6294-0335","observed_orcids":["https://orcid.org/0000-0002-6294-0335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas M. Pahl","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6294-0335","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025114625","display_name":"Torsten Hechler","orcid":"https://orcid.org/0000-0002-1000-8407","observed_orcids":["https://orcid.org/0000-0002-1000-8407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Torsten Hechler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1000-8407","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.0502999983727932,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.03550000116229057,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8420000076293945},{"id":"https://openalex.org/keywords/small-molecule-drug-conjugates","display_name":"small molecule-drug conjugates","score":0.8899999856948853},{"id":"https://openalex.org/keywords/fc-region","display_name":"Fc fragment","score":0.609000027179718},{"id":"https://openalex.org/keywords/alpha-amanitin","display_name":"alpha-amanitin","score":0.9039999842643738},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.7319999933242798},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7300000190734863},{"id":"https://openalex.org/keywords/plasma-half-life-extension","display_name":"plasma half-life extension","score":0.7369999885559082},{"id":"https://openalex.org/keywords/engineered-cysteines","display_name":"engineered cysteines","score":0.796999990940094},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7839000225067139},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7713000178337097},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5831000208854675},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5536999702453613},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.5511000156402588},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.46149998903274536},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.453900009393692},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4113999903202057},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3580000102519989},{"id":"https://openalex.org/C204628709","wikidata":"https://www.wikidata.org/wiki/Q864854","display_name":"Biotinylation","level":2,"score":0.34610000252723694},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32499998807907104},{"id":"https://openalex.org/C134066672","wikidata":"https://www.wikidata.org/wiki/Q1424639","display_name":"Payload (computing)","level":3,"score":0.3122999966144562},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3003999888896942},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29089999198913574},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.2904999852180481},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2863999903202057},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28610000014305115},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.2815999984741211},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.2768000066280365},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2736999988555908},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.27250000834465027},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.26759999990463257},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.26750001311302185},{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.26510000228881836},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.2556999921798706},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.250900000333786}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.8688008","doi":"https://doi.org/10.1158/1535-7163.c.8688008","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8688008","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.8688008","doi":"https://doi.org/10.1158/1535-7163.c.8688008","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8688008","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7137896840","https://openalex.org/W6891627055","https://openalex.org/W6891610778","https://openalex.org/W3138407875","https://openalex.org/W4392690017","https://openalex.org/W6966729842","https://openalex.org/W4387107512","https://openalex.org/W4292851178","https://openalex.org/W1867157284","https://openalex.org/W4391378593"],"abstract_inverted_index":{"Abstract":[0],"Prostate":[1],"cancer":[2,52],"remains":[3],"a":[4,66,70,74,105,142,151,239],"major":[5],"global":[6],"health":[7],"burden,":[8],"with":[9,107,150,226],"limited":[10,47],"options":[11],"and":[12,21,73,89,147,195,209,218],"poor":[13,90],"prognosis":[14],"in":[15,50,177,214,222,230],"advanced":[16],"stages.":[17],"To":[18],"extend":[19],"survival":[20],"improve":[22],"the":[23,108,117,125,160,171,182,201,227,236],"quality":[24],"of":[25,65,112,184],"life":[26],"for":[27,134,187,238,242],"patients,":[28],"targeted":[29],"therapies":[30],"have":[31,40,92,120],"become":[32],"an":[33,113,130,137,164,210],"emerging":[34],"treatment":[35,241],"modality.":[36],"Antibody\u2013drug":[37],"conjugates":[38,62],"(ADC)":[39],"shown":[41],"huge":[42],"clinical":[43,95],"success":[44],"but":[45,84],"only":[46],"therapeutic":[48],"effects":[49],"prostate":[51,243],"as":[53,69],"their":[54,81,85,94],"large":[55],"size":[56],"limits":[57],"tumor":[58,216],"penetration.":[59],"Small":[60],"molecule\u2013drug":[61,127],"(SMDC),":[63],"consisting":[64],"small":[67,126],"molecule":[68],"binding":[71],"moiety":[72],"cytotoxic":[75],"drug,":[76],"offer":[77],"advantages":[78],"due":[79],"to":[80,124,159,167,179,200],"smaller":[82],"size,":[83],"short":[86],"plasma":[87,193],"half-life":[88],"efficacy":[91,221],"hampered":[93],"breakthrough":[96],"so":[97],"far.":[98],"Fragment":[99],"crystallizable":[100],"(Fc)\u2013grafted":[101],"SMDCs":[102],"(Fc-SMDC)":[103],"combine":[104],"SMDC":[106],"half-life\u2013extending":[109],"Fc":[110,118,161],"fragment":[111],"antibody.":[114],"So":[115],"far,":[116],"fragments":[119],"been":[121],"attached":[122],"directly":[123,158],"complex,":[128],"making":[129],"enzymatic":[131],"cleavable":[132],"linker":[133],"payload":[135,155],"release":[136],"indispensable":[138],"prerequisite.":[139],"We":[140],"report":[141],"first-in-class":[143],"Fc-SMDC":[144],"targeting":[145,172],"PSMA":[146],"carrying":[148],"\u03b1-amanitin":[149],"noncleavable":[152,185,202],"linker.":[153],"The":[154],"is":[156],"conjugated":[157],"region":[162],"via":[163],"engineered":[165],"cysteine":[166],"separate":[168],"it":[169],"from":[170],"moiety.":[173],"This":[174],"approach":[175],"enables,":[176],"contrast":[178],"conventional":[180],"Fc-SMDCs,":[181],"use":[183],"linkers":[186],"minimal":[188],"premature":[189],"drug":[190],"release,":[191],"increased":[192],"stability,":[194],"low":[196],"systemic":[197],"toxicity.":[198],"Due":[199],"linker,":[203],"our":[204],"conjugate":[205],"showed":[206],"high":[207],"tolerability":[208,229],"extended":[211],"half-life,":[212],"resulting":[213],"prolonged":[215],"exposure":[217],"excellent":[219],"antitumor":[220],"xenograft":[223],"models.":[224],"Together":[225],"favorable":[228],"non-human":[231],"primates,":[232],"these":[233],"findings":[234],"highlight":[235],"potential":[237],"next-generation":[240],"cancer.":[244]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-02T00:00:00"}